Gauss Named to the 2019 CB Insights “Digital Health 150” List of Most Innovative Digital Health Companies
CB Insights today named Gauss to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world.
New York, N.Y. -- CB Insights today named Gauss to the inaugural Digital Health 150 ranking, showcasing the 150 most promising private digital health companies in the world. CB Insights CEO Anand Sanwal revealed the final Digital Health 150 during Future of Health, a gathering of top executives across some of the largest healthcare institutions, startups, and investment firms. Gauss Co-Founder and Chairman, Milton B. McColl M.D., is scheduled to present at the Future of Health conference on Thursday, October 3 at 11:05am on the Digital Health 150 Stage.
Gauss is transforming surgery with an AI-enabled mobile platform for the operating room. Based in Silicon Valley, the company leverages artificial intelligence, including machine learning and computer vision, to power surgical safety protocols by delivering real-time insights, simplifying clinical workflow, and closing communication gaps. The company’s flagship iPhone and iPad- compatible platform, Triton, is FDA cleared and CE Marked, and powers maternal hemorrhage protocols in hospitals performing over 250,000 annual procedures. The company recently announced the introduction of Triton Count, an AI-powered application built for the iPhone that supports best practices for surgical sponge counting.
“We’re honored to be recognized by CB Insights as one of the world’s most innovative digital health companies,” said Siddarth Satish, founder and Chief Executive Officer of Gauss. “The Triton system is having a real world clinical and economic impact on management of postpartum hemorrhage, the leading preventable cause of maternal mortality in the U.S. We’re incredibly excited about the progress we’re making to extend the Triton platform to other unmet medical needs by leveraging the power of AI and the simplicity and ubiquity of mobile devices.”
The Digital Health 150 companies span the globe, from Canada, China, Germany, Israel, the United States, and the United Kingdom, and are supported by more than 850 investors.
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
“From pharmaceuticals to patient care, technology is rapidly changing healthcare, and The Digital Health 150 showcases the 150 best startups spearheading innovation and change in the sector,” said CB Insights CEO Anand Sanwal. “It’s a privilege to use CB Insights’ data to identify and shine a light on these companies, and we look forward to tracking their success in 2019 and beyond.”
In 2018, these emerging private companies cumulatively raised $5.7B across 117 deals. They’re on track to surpass these numbers in 2019, with $3B raised across 73 deals as of Q2’19. Gauss has raised $45 million in venture capital. Most recently, the company closed a $20 million Series C co-led by Softbank Ventures and Northwell Health System.